Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Corrigendum to 'Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System-Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes' [JTO Clinical and Research Reports 6 (2025) 100914].
Journal: JTO clinical and research reports
Published: May 21, 2026
Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 21, 2026
Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 21, 2026
Mitochondrial Imaging Detects Early Cardiac Responses to Cancer Immunotherapy.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Effect of a Volunteer-Led Precision-Medicine Multilevel Intervention on Patient-Reported Outcomes, Receipt of Biomarker Testing, and Time to Treatment: A Randomized Clinical Trial.
Journal: JCO oncology practice
Published: September 15, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed EGFR-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy.
Journal: JTO clinical and research reports
Published: July 28, 2025
Molecular Markers in the Era of Precision Care in Lung Cancer.
Journal: Seminars in respiratory and critical care medicine
Published: July 07, 2025
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 08, 2025
Brief Report: Safety of Pulse-Dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-Mutated Nonsmall Cell Lung Cancer.
Journal: Clinical lung cancer
Published: May 23, 2025
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.
Journal: Nature communications
Published: May 11, 2025
Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System-Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes.
Journal: JTO clinical and research reports
Published: May 02, 2025
Erratum: Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights.
Journal: JCO oncology practice
Published: February 20, 2025
Last Updated: 09/26/2026